Literature DB >> 32185444

Evaluation of liver function using the hepatocyte enhancement fraction based on gadoxetic acid-enhanced MRI in patients with chronic hepatitis B.

Mao-Tong Liu1, Xue-Qin Zhang2, Jian Lu3, Tao Zhang1, Qi Chen4, Ji-Feng Jiang1, Ding Ding1, Sheng Du1, Wei-Bo Chen5.   

Abstract

OBJECTIVES: This study aimed to evaluate the feasibility of using the hepatocyte enhancement fraction (HEF) based on gadoxetic acid-enhanced magnetic resonance imaging (MRI) for assessing the liver function in patients with chronic hepatitis B.
METHODS: Sixty patients with Child-Pugh grade A (CP-A), 18 with Child-Pugh grade B (CP-B), 2 with Child-Pugh grade C (CP-C), and 20 with normal liver function (NLF) were enrolled. Gadolinium ethoxybenzyldiethy-lenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI was conducted. T1 mapping imaging was performed before and 20 min after Gd-EOB-DTPA administration. The pre- and post-contrast T1 values of the liver (T1pre and T1post), increase in the T1 relaxation rate (ΔR1), rate of decrease in the T1 relaxation time (ΔT1), HEF, and uptake coefficient (K) parameters in the NLF, CP-A, and CP-B + CP-C groups were compared using one-way analysis of variance. The effectiveness of each parameter in differentiating the NLF + CP-A group from the CP-B + CP-C group was evaluated using the receiver operating characteristic (ROC) curve.
RESULTS: The HEF, K, ΔT1, and ΔR1 values decreased, while the T1post and T1pre values increased, with the increase in liver function damage. Significant differences in T1post, ΔT1, ΔR1, and HEF were found between different groups, except for the CP-A and NLF groups. However, no significant difference was observed in the T1pre among the three groups. HEF exhibited the largest area under the ROC curve.
CONCLUSION: The HEF is an effective method for evaluating liver function in patients with hepatitis B.

Entities:  

Keywords:  Gd-EOB-DTPA; Liver function; Magnetic resonance imaging

Mesh:

Substances:

Year:  2020        PMID: 32185444     DOI: 10.1007/s00261-020-02478-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

Review 1.  Noninvasive imaging of hepatic dysfunction: A state-of-the-art review.

Authors:  Ting Duan; Han-Yu Jiang; Wen-Wu Ling; Bin Song
Journal:  World J Gastroenterol       Date:  2022-04-28       Impact factor: 5.374

2.  Evaluation of the ex vivo liver viability using a nuclear magnetic resonance relaxation time-based assay in a porcine machine perfusion model.

Authors:  Qing OuYang; Guohai Liang; Xiaoyu Tan; Xiran He; Lin Zhang; Weijian Kuang; Jianxiong Chen; Shaoping Wang; Mingju Liang; Feng Huo
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

3.  T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1.5 T and 3 T MRI.

Authors:  Verena Carola Obmann; Damiano Catucci; Annalisa Berzigotti; Christoph Gräni; Lukas Ebner; Johannes Thomas Heverhagen; Andreas Christe; Adrian Thomas Huber
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

4.  Intracellular accumulation capacity of gadoxetate: initial results for a novel biomarker of liver function.

Authors:  Ute Lina Fahlenkamp; Katharina Ziegeler; Lisa Christine Adams; Sarah Maria Böker; Günther Engel; Marcus Richard Makowski
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.